Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Perceptions of Chronic Disease Among Older African Americans: A Qualitative Analysis.

Phillips KL, Rogers CR, Aiken-Morgan AT.

J Health Dispar Res Pract. 2017 Winter;10(4):52-60.

2.

Public awareness of dementia: A study in Botucatu, a medium-sized city in the State of São Paulo, Brazil.

Schelp AO, Nieri AB, Hamamoto Filho PT, Bales AM, Mendes-Chiloff CL.

Dement Neuropsychol. 2008 Jul-Sep;2(3):192-196. doi: 10.1590/S1980-57642009DN20300005.

3.

African Americans are less likely to enroll in preclinical Alzheimer's disease clinical trials.

Zhou Y, Elashoff D, Kremen S, Teng E, Karlawish J, Grill JD.

Alzheimers Dement (N Y). 2016 Oct 15;3(1):57-64. doi: 10.1016/j.trci.2016.09.004. eCollection 2017 Jan.

4.

Dementia worry: a psychological examination of an unexplored phenomenon.

Kessler EM, Bowen CE, Baer M, Froelich L, Wahl HW.

Eur J Ageing. 2012 Sep 22;9(4):275-284. doi: 10.1007/s10433-012-0242-8. eCollection 2012 Dec.

5.

Persistence and adherence with dementia pharmacotherapy: relevance of patient, provider, and system factors.

Maxwell CJ, Stock K, Seitz D, Herrmann N.

Can J Psychiatry. 2014 Dec;59(12):624-31. Review.

6.

Public knowledge and beliefs about dementia risk reduction: a national survey of Australians.

Smith BJ, Ali S, Quach H.

BMC Public Health. 2014 Jun 28;14:661. doi: 10.1186/1471-2458-14-661.

7.

Knowledge and attitudes about Parkinson's disease among a diverse group of older adults.

Pan S, Stutzbach J, Reichwein S, Lee BK, Dahodwala N.

J Cross Cult Gerontol. 2014 Sep;29(3):339-52. doi: 10.1007/s10823-014-9233-x.

8.

Facilitating Alzheimer disease research recruitment.

Grill JD, Galvin JE.

Alzheimer Dis Assoc Disord. 2014 Jan-Mar;28(1):1-8. doi: 10.1097/WAD.0000000000000016. Review.

9.

An intervention to enhance Alzheimer's disease clinical research participation among older African Americans.

Jefferson AL, Lambe S, Romano RR, Liu D, Islam F, Kowall N.

J Alzheimers Dis. 2013;36(3):597-606. doi: 10.3233/JAD-130287.

10.

Preventing cognitive decline in older African Americans with mild cognitive impairment: design and methods of a randomized clinical trial.

Rovner BW, Casten RJ, Hegel MT, Leiby BE.

Contemp Clin Trials. 2012 Jul;33(4):712-20. doi: 10.1016/j.cct.2012.02.016. Epub 2012 Mar 2.

11.

Diversity and disparity in dementia: the impact of ethnoracial differences in Alzheimer disease.

Chin AL, Negash S, Hamilton R.

Alzheimer Dis Assoc Disord. 2011 Jul-Sep;25(3):187-95. doi: 10.1097/WAD.0b013e318211c6c9. Review.

12.

Changes to perceptions of the pros and cons of genetic susceptibility testing after APOE genotyping for Alzheimer disease risk.

Christensen KD, Roberts JS, Uhlmann WR, Green RC.

Genet Med. 2011 May;13(5):409-14. doi: 10.1097/GIM.0b013e3182076bf1.

13.

Barriers and facilitators of African American participation in Alzheimer disease biomarker research.

Williams MM, Scharff DP, Mathews KJ, Hoffsuemmer JS, Jackson P, Morris JC, Edwards DF.

Alzheimer Dis Assoc Disord. 2010 Jul-Sep;24 Suppl:S24-9. doi: 10.1097/WAD.0b013e3181f14a14.

14.

"I know what you told me, but this is what I think:" perceived risk of Alzheimer disease among individuals who accurately recall their genetics-based risk estimate.

Linnenbringer E, Roberts JS, Hiraki S, Cupples LA, Green RC.

Genet Med. 2010 Apr;12(4):219-27. doi: 10.1097/GIM.0b013e3181cef9e1.

15.

Ethnic differences in beliefs regarding Alzheimer disease among dementia family caregivers.

Gray HL, Jimenez DE, Cucciare MA, Tong HQ, Gallagher-Thompson D.

Am J Geriatr Psychiatry. 2009 Nov;17(11):925-33. doi: 10.1097/JGP.0b013e3181ad4f3c.

16.

Risk perception and preference for prevention of Alzheimer's disease.

Chung S, Mehta K, Shumway M, Alvidrez J, Perez-Stable EJ.

Value Health. 2009 Jun;12(4):450-8. doi: 10.1111/j.1524-4733.2008.00482.x. Epub 2009 Jan 12.

17.

Disclosure of APOE genotype for risk of Alzheimer's disease.

Green RC, Roberts JS, Cupples LA, Relkin NR, Whitehouse PJ, Brown T, Eckert SL, Butson M, Sadovnick AD, Quaid KA, Chen C, Cook-Deegan R, Farrer LA; REVEAL Study Group.

N Engl J Med. 2009 Jul 16;361(3):245-54. doi: 10.1056/NEJMoa0809578.

18.

Recent trends in Alzheimer disease mortality in the United States, 1999 to 2004.

Steenland K, MacNeil J, Vega I, Levey A.

Alzheimer Dis Assoc Disord. 2009 Apr-Jun;23(2):165-70.

19.

Perceptions of familial risk in those seeking a genetic risk assessment for Alzheimer's disease.

Hiraki S, Chen CA, Roberts JS, Cupples LA, Green RC.

J Genet Couns. 2009 Apr;18(2):130-6. doi: 10.1007/s10897-008-9194-8. Epub 2008 Oct 23.

20.

Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experience.

Christensen KD, Roberts JS, Royal CD, Fasaye GA, Obisesan T, Cupples LA, Whitehouse PJ, Butson MB, Linnenbringer E, Relkin NR, Farrer L, Cook-Deegan R, Green RC.

Genet Med. 2008 Mar;10(3):207-14. doi: 10.1097/GIM.0b013e318164e4cf.

Supplemental Content

Support Center